ADVENTRX Pharmaceuticals, Inc. (AMEX: ANX), a biopharmaceutical company, is dedicated to in-licensing, developing and commercializing proprietary product candidates. Their key focus is on the treatment of cancer. The Company intends to enhance the performance and commercial potential of existing treatments by addressing issues related with these treatment regimens. For further information, visit the Company’s web site at www.adventrx.com.
- 17 years ago
QualityStocks
ADVENTRX Pharmaceuticals, Inc. (AMEX: ANX)
Tags Rodman & Renshaw
Related Post
-
Trilogy Metals Inc. (NYSE American: TMQ) (TSX: TMQ) Year-End Report Shows Alignment with Domestic Resource Priorities, Strong Strategic Positioning
Disseminated on behalf of Trilogy Metals Inc. (NYSE American: TMQ) (TSX: TMQ) and may include…
-
CMX Gold & Silver Corp. (CSE: CXC) (OTC: CXXMF) to Execute Comprehensive Exploration Plan Focused on Promising Potential of Multiple Additional Silver-Bearing Veins
Disseminated on behalf of CMX Gold & Silver Corp. (CSE: CXC) (OTC: CXXMF) and may…
-
Scaling Care, Tightening Controls: How Earth Science Tech Inc. (ETST) Is Building a Multi-Unit Healthcare Platform
Earth Science Tech reported fiscal Q3 2026 revenue of $8.4 million, up 14.1% year over…